Profile data is unavailable for this security.
About the company
SOHM, Inc. is a pharmaceutical, cosmeceutical and nutraceutical and biotech manufacturer that produces and markets generic drugs and products for all major treatment categories. The Company is focused on developing, manufacturing and distributing generic, branded generic, private label pharmaceuticals, cosmeceuticals and nutraceutical products. The Company’s products include Omega-3 with EPA, DHA & Vitamin D3, I-Prolec, Various Gummies, Levetiracetam, Hydroquinone USP, 4%, Sodium Sulfacetamide 10% Sulfur 2%, Sodium Sulfacetamide 9.8% Sulfur 4.8%, Sodium Sulfacetamide 10% Sulfur 5%, Nail Renovar, and Fohm by SOHM. The Company’s generic pharmaceuticals are exported globally with a focus on distribution in markets in Africa, Latin America, and Southeast Asia. It has also acquired the intellectual property portfolio entitled Cas 9 retroviral integrase and Cas 9 recombinase systems for targeted incorporation of a DNA sequence into a genome of a cell or organism.
- Revenue in USD (TTM)--
- Net income in USD--
- Incorporated2005
- Employees--
- LocationSOHM Inc4195 Chino Hills Parkway, Ste 675CHINO HILLS 91709United StatesUSA
- Phone+1 (714) 522-6700
- Fax+1 (714) 523-4329
- Websitehttps://www.sohm.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procyon Corp | 4.98m | -312.97k | 1.53m | 19.00 | -- | 0.7027 | -- | 0.307 | -0.0387 | -0.0387 | 0.6138 | 0.2817 | 1.47 | 2.32 | 9.90 | 262,338.40 | -10.08 | 1.19 | -12.70 | 1.44 | 78.07 | 74.40 | -6.84 | 0.8691 | 2.41 | -- | 0.00 | -- | 6.35 | 3.53 | -367.38 | -- | 17.32 | -- |
| Universe Pharmaceuticals Inc | 17.86m | -3.67m | 1.61m | 216.00 | -- | 0.0287 | -- | 0.0902 | -10.13 | -10.13 | 39.18 | 99.64 | 0.2602 | 5.88 | 1.38 | 82,679.35 | -5.35 | -5.40 | -7.08 | -7.09 | 35.28 | 43.33 | -20.56 | -9.65 | 3.90 | -17.46 | 0.1416 | -- | -22.44 | -10.27 | 57.92 | -- | 46.30 | -- |
| Stemcell Holdings Inc | 9.98m | 3.10m | 1.64m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 1.90m | 40.00 | -- | -- | -- | 0.6858 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 2.58 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Bio Essence Corp | 565.67k | -160.45k | 2.08m | 2.00 | -- | -- | -- | 3.67 | -0.0042 | -0.0042 | 0.0149 | -0.0816 | 1.26 | -- | 16.06 | 282,835.00 | -35.64 | -40.94 | -- | -- | 69.28 | 38.36 | -28.36 | -134.00 | -- | -57.42 | -- | -- | -- | -17.08 | -286.98 | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 2.21m | 16.00 | 284.00 | 3.09 | -- | 3.09 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PRF Technologies Ltd | 0.00 | -4.09m | 2.32m | 2.00 | 0.0098 | 0.1412 | -- | -- | 301.27 | 301.27 | 0.00 | 20.97 | 0.00 | -- | -- | 0.00 | -57.27 | -71.03 | -118.06 | -84.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.12 | -- | -- | -- |
| Scisparc Ltd | -100.00bn | -100.00bn | 2.59m | 2.00 | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -- | -63.15 | -- | -90.87 | -- | -- | -- | -456.81 | 0.5151 | -- | 1.04 | -- | -54.64 | -- | -22.69 | -- | -- | -- |
| SOHM Inc | -100.00bn | -100.00bn | 2.60m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Jaguar Health Inc | 11.79m | -40.29m | 2.87m | 49.00 | -- | 0.7415 | -- | 0.2433 | -54.06 | -54.06 | 12.98 | 1.53 | 0.2184 | 0.2099 | 8.78 | 240,510.20 | -76.04 | -90.27 | -152.77 | -144.36 | 81.92 | 75.33 | -348.22 | -458.25 | 0.5197 | -4.62 | 0.8759 | -- | 19.75 | 15.14 | 6.80 | -- | -- | -- |
| China Pharma Holdings Inc | 4.05m | -3.19m | 3.18m | 224.00 | -- | 0.3825 | -- | 0.7849 | -1.10 | -1.10 | 1.28 | 1.66 | 0.2769 | 2.17 | 14.52 | 18,090.54 | -21.80 | -18.69 | -35.67 | -37.95 | -10.94 | -1.14 | -78.72 | -44.96 | 0.1026 | -30.50 | 0.2884 | -- | -35.41 | -16.15 | -53.84 | -- | 16.49 | -- |
| CYANOTECH CORP | 25.27m | -1.78m | 3.25m | 83.00 | -- | 0.4033 | 17.21 | 0.1287 | -0.2469 | -0.2469 | 3.51 | 1.09 | 1.05 | 2.21 | 12.81 | 304,433.80 | -7.41 | -6.08 | -13.42 | -8.05 | 32.00 | 32.26 | -7.03 | -6.37 | 0.2988 | -1.47 | 0.5089 | -- | 4.96 | -5.36 | 39.19 | -- | 1.97 | -- |
| Functional Brands Inc | 6.80m | -377.56k | 3.44m | 32.00 | -- | 2.47 | -- | 0.5067 | -0.0546 | -0.0546 | 0.9614 | 0.0854 | 0.8873 | 0.3527 | 37.24 | 212,408.80 | -4.93 | -- | -9.96 | -- | 91.06 | -- | -5.55 | -- | 0.4419 | -0.8723 | 0.6346 | -- | -3.72 | -- | 54.93 | -- | -- | -- |
